companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

CARLYLE

LEXINGTON-USA

Company Name:
Corporate Name:
CARLYLE
Company Title: apathykills.org 
Company Description:  
Keywords to Search:  
Company Address: 214 e central blvd,LEXINGTON,MO,USA 
ZIP Code:
Postal Code:
64067 
Telephone Number: 8167922446 (+1-816-792-2446) 
Fax Number:  
Website:
apathykills. org 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
9999 
USA SIC Description:
Unclassified 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
LOGICAL-LEARNING
PICKET FENCE
QUALITY CARE CONSULTANTS
Next company profile:
ALPINE CATERING
PAYLOAD COMPUTER SERVICES
RYAN CALDER










Company News:
  • Carlyle | Global Investment Firm
    With $453 billion of assets under management, Carlyle’s purpose is to invest wisely and create value on behalf of our investors, portfolio companies, and communities
  • Annual Report 2024 | Carlyle
    The 2024 Annual Report highlights Carlyle’s platform strength, disciplined execution, and our ability to navigate evolving markets to deliver long-term value With a global footprint, innovative mindset, and focused investment approach, we are well-positioned to lead in the next phase of private market evolution
  • Our People - Carlyle
    Brian A Bernasek is a Partner and Co-Head of Americas Corporate Private Equity at Carlyle Carlyle’s Americas Corporate Private Equity business has $67 billion in assets under management with diversified investments spanning industries, geographies, and strategies
  • Global Private Equity - Carlyle
    Carlyle’s Global Private Equity business is one of the world’s largest and most diversified private equity platforms, spanning industries, geographies and strategies to deliver transformational results for our partners—management teams, portfolio companies, and fund investors
  • Our Firm - Carlyle
    Carlyle is one of the world’s largest and most diversified global investment firms, with $453 billion of assets under management across 3 business segments and 641 investment vehicles Founded in 1987 in Washington, DC, our global team today is comprised of more than 2,300 professionals operating in 29 offices across 4 continents
  • News Media - Carlyle
    Stay updated on Carlyle’s latest news and insights from around the world For more, follow Carlyle on LinkedIn and X
  • Carlyle Reports Fourth Quarter and Full-Year 2024 Financial Results
    Carlyle Fourth Quarter and Full-Year 2024 U S GAAP Results •Fund management fees increased 7% in FY 2024 compared to FY 2023, primarily driven by an increase in capital market fees, an increase in fundraising in our Global Investment Solutions and Global Credit
  • PUBLIC INVESTORS | The Carlyle Group
    The Investor Relations website contains information about The Carlyle Group's business for stockholders, potential investors, and financial analysts
  • bluebird bio Announces Definitive Agreement to be Acquired by Carlyle . . .
    Carlyle and SK Capital will provide bluebird primary capital to scale bluebird’s commercial delivery of gene therapies for patients with sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy
  • Carlyle Reports Third Quarter 2024 Financial Results
    Carlyle Third Quarter 2024 U S GAAP Results Net income attributable to The Carlyle Group Inc common stockholders was $596 million for Q3 2024, or $1 63 per share on a diluted basis




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer